Search
Menu
Home
HTB
2019
December
13
HTB
13 December 2019
Contents
Editorial
i-Base 2019 appeal: we need your help….
HTB 13 December 2019 online
Supplements
Introduction to ART – October 2019
UK Guide to PrEP – November 2019
Conference reports
17th European AIDS Conference (EACS 2019)
Capsid inhibitor GS-6207 (lenacapavir): potential for 6 monthly dosing for MDR HIV
Dolutegravir/lamivudine as dual ART
Weight changes with doravirine-based first line therapy
Bone and renal changes in the ADVANCE trial
10th International Workshop on HIV and Ageing
Impact of isolation and loneliness on older people living with HIV
Antiretrovirals
Doravirine approved by NHS England as single NNRTI and as part of FDC with 3TC/TDF
Fostemsavir submitted to US FDA for multidrug resistant HIV
Paediatric dispersible formulation of dolutegravir submitted to EMA and FDA
Lipodystrophy and metabolic complications
Tesamorelin for NAFLD in people living with HIV
PDFs
13 December 2019 vol 20 no 14
HTB RSS
Early access
INSTIs and cardiovascular events in the RESPOND cohort: early increase at six months normalises after two years
29 June 2022
Monkeypox crisis in the UK needs urgent funding: sex, vaccines and Pride
27 June 2022
Gonorrhoea vaccine might halve infections and help combat drug resistance
26 June 2022
Importance of booster vaccine to protect against emergent COVID-19 strains
26 June 2022
All early access reports
Current issues
June 2022
May 2022
April 2022
Back issues
Special report
Monkeypox crisis in the UK needs urgent funding: sex, vaccines and Pride
27 June 2022
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage